APA (7th ed.) Citation

Hoffmann, K., Ganten, T. M., Gotthardt, D., Radeleff, B., Karapanagiotou-Schenkel, I., Kalle, C. v., . . . Schemmer, P. (2016). Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial. BioMed Central.

Chicago Style (17th ed.) Citation

Hoffmann, Katrin, Tom M. Ganten, Daniel Gotthardt, Boris Radeleff, Irini Karapanagiotou-Schenkel, Christof von Kalle, Dirk Jäger, Markus W. Büchler, and Peter Schemmer. Impact of Neo-adjuvant Sorafenib Treatment on Liver Transplantation in HCC Patients - a Prospective, Randomized, Double-blind, Phase III Trial. London: BioMed Central, 2016.

MLA (9th ed.) Citation

Hoffmann, Katrin, et al. Impact of Neo-adjuvant Sorafenib Treatment on Liver Transplantation in HCC Patients - a Prospective, Randomized, Double-blind, Phase III Trial. BioMed Central, 2016.